Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Zendy

Hossein Taheri | Zendy; Kristian B. Filion | Zendy; Sarah B. Windle | Zendy; Pascal Reynier | Zendy; Mark J. Eisenberg | Zendy

Open Access

Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Author(s) -

Hossein Taheri,

Kristian B. Filion,

Sarah B. Windle,

Pascal Reynier,

Mark J. Eisenberg

Publication year - 2020

Publication title -

cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.547

H-Index - 63

eISSN - 1421-9751

pISSN - 0008-6312

DOI - 10.1159/000505365

Subject(s) - cholesterylester transfer protein , medicine , mace , randomized controlled trial , meta analysis , cholesterol , lipoprotein , myocardial infarction , percutaneous coronary intervention

Cholesteryl ester transfer protein (CETP) inhibitors increase serum high-density lipoprotein cholesterol (HDL-c) concentration; however, their impact on cardiovascular outcomes is not clear. This systematic review examines the effect of CETP inhibitors on serum lipid profiles, cardiovascular events, and all-cause mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research